Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers

被引:10
|
作者
Dominguez-Vivero, Clara [1 ]
Wu, Liwen [2 ]
Lee, Seonjoo [2 ]
Manoochehri, Masood [1 ]
Cines, Sarah [1 ,7 ]
Brickman, Adam M. [1 ]
Rizvi, Batool [1 ]
Chesebro, Anthony [1 ]
Gazes, Yunglin [1 ]
Fallon, Emer [5 ]
Lynch, Timothy [5 ]
Heidebrink, Judith L. [6 ]
Paulson, Henry [6 ]
Goldman, Jill S. [1 ]
Huey, Edward [1 ,3 ,4 ]
Cosentino, Stephanie [1 ]
机构
[1] Columbia Univ, Dept Neurol, Cognit Neurosci Div, Taub Inst,GH Sergievsky Ctr, New York, NY USA
[2] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA
[3] Columbia Univ, Dept Psychiat, New York, NY USA
[4] Columbia Univ, New York State Psychiat Inst, New York, NY USA
[5] Dublin Neurol Inst, Dublin, Ireland
[6] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
[7] Fairleigh Dickinson Univ, Teaneck, NJ USA
关键词
Atrophy; brain atrophy; early detection; frontotemporal lobar degeneration; MAPT mutation; FRONTOTEMPORAL LOBAR DEGENERATION; WHITE-MATTER HYPERINTENSITIES; PRESYMPTOMATIC MAPT; DEMENTIA; ATROPHY; TAU; PROGRANULIN; PATTERNS; C9ORF72; GENFI;
D O I
10.3233/JAD-190820
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Frontotemporal dementia (FTD) is the second most common cause of early-onset neurodegenerative dementia. Several studies have focused on early imaging changes in FTD patients, but once subjects meet full criteria for FTD diagnosis, structural changes are generally widespread. Objective: This study aims to determine the earliest structural brain changes in asymptomatic MAPT MUTATION carriers. Methods: This is a cross-sectional multicenter study comparing global and regional brain volume and white matter integrity in a group of MAPT mutation preclinical carriers and controls. Participants belong to multiple generations of six families with five MAPT mutations. All participants underwent a medical examination, neuropsychological tests, genetic analysis, and a magnetic resonance scan (3T, scout, T1-weighted image followed by EPI (BOLD), MPRAGE, DTI, FLAIR, and ASL sequences). Results: Volumes of five cortical and subcortical areas were strongly correlated with mutation status: temporal lobe (left amygdala, left temporal pole), cingulate cortex (left rostral anterior cingulate gyrus, right posterior cingulate), and the lingual gyrus in the occipital lobe. We did not find significant differences in whole brain volume, white matter hyperintensities volume, and white matter integrity using DTI analysis. Conclusion: Temporal lobe, cingulate cortex and the lingual gyrus seem to be early targets of the disease and may serve as biomarkers for FTD prior to overt symptom onset.
引用
收藏
页码:595 / 606
页数:12
相关论文
共 50 条
  • [41] Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
    Julie Gonneaud
    Alex T. Baria
    Alexa Pichet Binette
    Brian A. Gordon
    Jasmeer P. Chhatwal
    Carlos Cruchaga
    Mathias Jucker
    Johannes Levin
    Stephen Salloway
    Martin Farlow
    Serge Gauthier
    Tammie L. S. Benzinger
    John C. Morris
    Randall J. Bateman
    John C. S. Breitner
    Judes Poirier
    Etienne Vachon-Presseau
    Sylvia Villeneuve
    Nature Communications, 12
  • [42] Pre-clinical models in pediatric traumatic brain injury—challenges and lessons learned
    Patrick M. Kochanek
    Jessica S. Wallisch
    Hülya Bayır
    Robert S. B. Clark
    Child's Nervous System, 2017, 33 : 1693 - 1701
  • [43] PAEDIATRIC BRAIN TUMOUR PRE-CLINICAL MODELS ENCYCLOPAEDIA: A COLLABORATIVE PROJECT PROPOSAL
    Ivanov, Delyan
    Grabowska, Anna
    Grundy, Richard
    Walker, David
    NEURO-ONCOLOGY, 2016, 18 : 143 - 143
  • [44] PRE-CLINICAL STUDY OF HISTONE METHYL TRANSFERASE INHIBITOR IN PEDIATRIC BRAIN TUMORS
    Bochare, Sunil
    Khatua, Soumen
    Gopalakrishnan, Vidya
    NEURO-ONCOLOGY, 2012, 14 : 104 - 104
  • [45] Leveraging Brain Death as a Novel Pre-Clinical Human Model: The Parsons Model
    Jones-Carr, Maggie
    Perry, Jackson
    Reed, Rhiannon
    Killian, Cozette
    Baker, Gavin
    Porrett, Paige
    Anderson, Douglas
    Kumar, Vineeta
    Shunk, Andrew
    Locke, Jayme
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S6 - S6
  • [46] Antipsychotic Drugs: The Antithesis to Neurorehabilitation in Models of Pre-Clinical Traumatic Brain Injury
    Race, Nicholas S.
    Moschonas, Eleni H.
    Cheng, Jeffrey P.
    Bondi, Corina O.
    Kline, Anthony E.
    NEUROTRAUMA REPORTS, 2023, 4 (01): : 724 - 735
  • [47] Accelerated functional brain aging in pre-clinical familial Alzheimer's disease
    Gonneaud, Julie
    Baria, Alex T.
    Binette, Alexa Pichet
    Gordon, Brian A.
    Chhatwal, Jasmeer P.
    Cruchaga, Carlos
    Jucker, Mathias
    Levin, Johannes
    Salloway, Stephen
    Farlow, Martin
    Gauthier, Serge
    Benzinger, Tammie L. S.
    Morris, John C.
    Bateman, Randall J.
    Breitner, John C. S.
    Poirier, Judes
    Vachon-Presseau, Etienne
    Villeneuve, Sylvia
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [48] Structural Abnormalities of the Optic Nerve and Retina in Huntington's Disease Pre-Clinical and Clinical Settings
    Mazur-Michalek, Iwona
    Kowalska, Katarzyna
    Zielonka, Daniel
    Lesniczak-Staszak, Marta
    Pietras, Paulina
    Szaflarski, Witold
    Isalan, Mark
    Mielcarek, Michal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [49] USING A ZEBRAFISH PEDIATRIC BRAIN TUMOR MODEL FOR PRE-CLINICAL DRUG SCREENING
    Modzelewska, Katarzyna
    Picard, Daniel
    Boer, Elena
    Miles, Rodney
    Jensen, Randy
    Pysher, Theodore
    Schiffman, Joshua
    Jette, Cicely
    Huang, Annie
    Stewart, Rodney
    NEURO-ONCOLOGY, 2015, 17 : 33 - 33
  • [50] Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases
    Bannach, O.
    Reinartz, E.
    Henke, F.
    Dressen, F.
    Oelschlegel, A.
    Kaatz, M.
    Groschup, M. H.
    Willbold, D.
    Riesner, D.
    Birkmann, E.
    VETERINARY MICROBIOLOGY, 2013, 166 (1-2) : 102 - 108